Sim&Cure Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 24
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $3.35M
Latest Deal Amount
  • Investors
  • 5

Sim&Cure General Information

Description

Developer of a patient-specific device designed to secure the treatment of a cerebral aneurysm. The company's device is fast and optimal sizing, virtually evaluates the final position of different sizes and shapes of intracranial implants, and secures the treatment, enabling neurologists to effectively treat patients with neurovascular disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Decision/Risk Analysis
Other Healthcare Technology Systems
Primary Office
  • 95 rue Pierre Flourens, Bât H
  • 34090 Montpellier
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sim&Cure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 23-May-2019 $3.35M 00.000 0000 Completed Generating Revenue
4. Early Stage VC 17-Dec-2015 00000 00000 00.000 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2015 00000 00000 Completed Generating Revenue
2. Accelerator/Incubator $6.56K Completed Startup
1. Accelerator/Incubator 01-Jan-2013 $6.56K $6.56K Completed Startup
To view Sim&Cure’s complete valuation and funding history, request access »

Sim&Cure Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Shares 00,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 00.000
To view Sim&Cure’s complete cap table history, request access »

Sim&Cure Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a patient-specific device designed to secure the treatment of a cerebral aneurysm. The company's device is
Therapeutic Devices
Montpellier, France
24 As of 2021
00.000
000 0000-00-00
00000000000 00.000

00000000

consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat n
00000 0000000000 0000000000 0000000
Minneapolis, MN
00000 As of 0000
00000000

00000 00

nderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupid
00000000000 0000000
Shelton, CT
000 As of 0000
00000
000000000 - 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sim&Cure Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Medtronic Corporation Minneapolis, MN 00000 00000000
00000 0000 Venture Capital-Backed Shelton, CT 000 00000 000000000 - 00000
000 000000 Formerly PE-Backed Lewisville, TX 0000 00000 000000&0 00000
00000000000 000000 Venture Capital-Backed Redmond, WA 00 00000 00000000000 00000
To view Sim&Cure’s complete competitors history, request access »

Sim&Cure Executive Team (4)

Name Title Board Seat Contact Info
Mathieu Sanchez Ph.D Co-Founder, Chief Executive Officer & Chairman
Vincent Costalat Co-Founder
Dominique Ambard Ph.D Vice President of Engineering
You’re viewing 3 of 4 executive team members. Get the full list »

Sim&Cure Board Members (7)

Name Representing Role Since
Alexis Frentz Elaia Partners Board Observer 000 0000
Daniel Pilaud Ph.D IT-Translation Board Member 000 0000
Gonzague Issenmann Self Board Member 000 0000
Jean-Nicolas Vernin Self Board Member 000 0000
Julien Jomier Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Sim&Cure Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sim&Cure Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Elaia Partners Venture Capital Minority 000 0000 000000 0
IT-Translation Venture Capital Minority 000 0000 000000 0
i-Lab LUISS Accelerator/Incubator Minority 000 0000 000000 0
Languedoc Roussillon Incubation Accelerator/Incubator Minority 000 0000 000000 0
Montpellier Mediterranee Metropole (Cap Alpha Incubator) Accelerator/Incubator Minority 000 0000 000000 0
To view Sim&Cure’s complete investors history, request access »